BRIM-DOR PF- brimonidine - dorzolamide pf solution/ drops 
ImprimisRx NJ

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

Store at 20° to 25° C (68° to 77° F)

Bottle Label

Bottle Label

BRIM-DOR PF 
brimonidine - dorzolamide pf solution/ drops
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:70261-518
Route of AdministrationOPHTHALMIC
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BRIMONIDINE TARTRATE (UNII: 4S9CL2DY2H) (BRIMONIDINE - UNII:E6GNX3HHTE) BRIMONIDINE1.5 mg  in 1 mL
DORZOLAMIDE HYDROCHLORIDE (UNII: QZO5366EW7) (DORZOLAMIDE - UNII:9JDX055TW1) DORZOLAMIDE20 mg  in 1 mL
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:70261-518-1010 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product01/01/2018
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other01/01/2018
Labeler - ImprimisRx NJ (931390178)

Revised: 5/2018
Document Id: 6bb58e03-7db4-23a2-e053-2a91aa0a8800
Set id: 6bb58e03-7db3-23a2-e053-2a91aa0a8800
Version: 1
Effective Time: 20180508
 
ImprimisRx NJ